|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.985 USD | +0.76% |
|
-71.86% | -72.89% |
| 07-31 | Top Midday Decliners | MT |
| 07-31 | Baird Downgrades Karyopharm Therapeutics to Neutral From Outperform, Adjusts Price Target to $3 From $15 | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 4.65 | 4.65 | 4.55 |
| Spread/Res. | -57.10% | -57.10% | -56.15% |
| Spread/Supp. | +3.91% | +3.91% | +3.91% |
| Support | 1.92 | 1.92 | 1.92 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KPTI Stock
- Charts Karyopharm Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
